XASXNVU
Market cap12mUSD
Jan 08, Last price
0.03AUD
1D
2.86%
1Q
89.47%
IPO
-64.00%
Name
Nanoveu Ltd
Chart & Performance
Profile
Nanoveu Limited, a technology company, develops and sells nanotechnology applications for consumer devices in the Americas and internationally. The company provides Nanoshield, an antiviral protector, which is available in various mobile phone screen covers and cases, as well as a commercial film for various surface applications. It also offers EyeFly3D that converts 2D digital displays into 3D without the need for 3D glasses. In addition, the company is developing Customskins vending machines for precisely applying screen covers to mobile phones in just over a minute; EyeFyx, a vision correction solution using hardware and software to manipulate screen output; and anti-flamatory coating technology used in plastic laminates for the aviation and transport sectors. The company was incorporated in 2018 and is based in Subiaco, Australia.
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑10 | 2015‑10 | |
Income | |||||||||
Revenues | 103 -35.72% | 160 -79.58% | |||||||
Cost of revenue | 1,639 | 2,392 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | (1,536) | (2,233) | |||||||
NOPBT Margin | |||||||||
Operating Taxes | 153 | ||||||||
Tax Rate | |||||||||
NOPAT | (1,536) | (2,385) | |||||||
Net income | (2,160) -24.48% | (2,860) 6.50% | |||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | 1,981 | 468 | |||||||
BB yield | -22.59% | ||||||||
Debt | |||||||||
Debt current | 219 | 300 | |||||||
Long-term debt | 81 | ||||||||
Deferred revenue | |||||||||
Other long-term liabilities | 418 | ||||||||
Net debt | 227 | 52 | |||||||
Cash flow | |||||||||
Cash from operating activities | (2,006) | (2,815) | |||||||
CAPEX | 1 | ||||||||
Cash from investing activities | |||||||||
Cash from financing activities | 1,831 | 142 | |||||||
FCF | (1,605) | (1,854) | |||||||
Balance | |||||||||
Cash | 73 | 248 | |||||||
Long term investments | |||||||||
Excess cash | 68 | 240 | |||||||
Stockholders' equity | (109) | (273) | |||||||
Invested Capital | 225 | 300 | |||||||
ROIC | |||||||||
ROCE | |||||||||
EV | |||||||||
Common stock shares outstanding | 375,334 | 230,338 | |||||||
Price | 0.01 -70.97% | ||||||||
Market cap | 2,073 -61.46% | ||||||||
EV | 2,125 | ||||||||
EBITDA | (1,368) | (2,188) | |||||||
EV/EBITDA | |||||||||
Interest | 15 | 176 | |||||||
Interest/NOPBT |